FULC
Fulcrum Therapeutics, Inc. · Healthcare
Director Robert J Gould sold $135K of Fulcrum Therapeutics, Inc.
Sold$135,228
$24.02Price
5,631Shares
−1%Stake
What FULC did after the filing
- The stock from Mon, Apr 11 close, $18.36
- −54.5%
- S&P 500, same days
- −10.5%
Measured over 30 trading days, to the May 24 close.
Traded Thu, Apr 7. Filed Mon, Apr 11, 1:00 PM ET, during the session. Returns use the Apr 11 close and the May 24 close. Not investment advice.